197 related articles for article (PubMed ID: 38285111)
1. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study.
Naaktgeboren WR; Koevoets EW; Stuiver MM; van Harten WH; Aaronson NK; van der Wall E; Velthuis M; Sonke G; Schagen SB; Groen WG; May AM
Breast Cancer Res Treat; 2024 May; 205(1):75-86. PubMed ID: 38285111
[TBL] [Abstract][Full Text] [Related]
2. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
4. Exercise for women receiving adjuvant therapy for breast cancer.
Furmaniak AC; Menig M; Markes MH
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD005001. PubMed ID: 27650122
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
7. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
[TBL] [Abstract][Full Text] [Related]
8. Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.
Oberste M; Schaffrath N; Schmidt K; Bloch W; Jäger E; Steindorf K; Hartig P; Joisten N; Zimmer P
BMC Cancer; 2018 Nov; 18(1):1071. PubMed ID: 30400840
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study.
Hartman SJ; Nelson SH; Myers E; Natarajan L; Sears DD; Palmer BW; Weiner LS; Parker BA; Patterson RE
Cancer; 2018 Jan; 124(1):192-202. PubMed ID: 28926676
[TBL] [Abstract][Full Text] [Related]
10. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study).
Koevoets EW; Schagen SB; de Ruiter MB; Geerlings MI; Witlox L; van der Wall E; Stuiver MM; Sonke GS; Velthuis MJ; Jobsen JJ; Menke-Pluijmers MBE; Göker E; van der Pol CC; Bos MEMM; Tick LW; van Holsteijn NA; van der Palen J; May AM; Monninkhof EM;
Breast Cancer Res; 2022 May; 24(1):36. PubMed ID: 35619188
[TBL] [Abstract][Full Text] [Related]
11. Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.
Witlox L; Schagen SB; de Ruiter MB; Geerlings MI; Peeters PHM; Koevoets EW; van der Wall E; Stuiver M; Sonke G; Velthuis MJ; Palen JAMV; Jobsen JJ; May AM; Monninkhof EM
BMJ Open; 2019 Jun; 9(6):e028117. PubMed ID: 31227537
[TBL] [Abstract][Full Text] [Related]
12. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
13. Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study.
Chen BT; Ghassaban K; Jin T; Patel SK; Ye N; Sun CL; Kim H; Rockne RC; Mark Haacke E; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
Magn Reson Imaging; 2018 Dec; 54():218-224. PubMed ID: 30076946
[TBL] [Abstract][Full Text] [Related]
14. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy.
Apple AC; Schroeder MP; Ryals AJ; Wagner LI; Cella D; Shih PA; Reilly J; Penedo FJ; Voss JL; Wang L
Neuroimage Clin; 2018; 20():110-118. PubMed ID: 30094161
[TBL] [Abstract][Full Text] [Related]
16. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
Hermelink K; Bühner M; Sckopke P; Neufeld F; Kaste J; Voigt V; Münzel K; Wuerstlein R; Ditsch N; Hellerhoff K; Rjosk-Dendorfer D; Braun M; von Koch FE; Härtl K; Hasmüller S; Bauerfeind I; Debus G; Herschbach P; Mahner S; Harbeck N
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521364
[TBL] [Abstract][Full Text] [Related]
18. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
19. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
